We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · August 05, 2020

Corticosteroid Complications in the Management of ICI-Related Diarrhea and Colitis in Advanced Melanoma

ESMO open

 

Additional Info

ESMO open
Five-Year Review of Corticosteroid Duration and Complications in the Management of Immune Checkpoint Inhibitor-Related Diarrhoea and Colitis in Advanced Melanoma
ESMO Open 2020 Jul 01;5(4)e000585, DM Favara, L Spain, L Au, J Clark, E Daniels, S Diem, D Chauhan, S Turajlic, N Powell, JM Larkin, N Yousaf

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading